Round Rock Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Round Rock Advisors's ABBV Position: Q2 2026 in Review
Round Rock Advisors reduced its AbbVie (ABBV) stake by 0.27% in Q2 2026, selling an estimated $10.3K and leaving 18,032 shares worth $4.54M. The position accounts for 0.58% of the portfolio, ranked #22.
Round Rock Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Round Rock Advisors held 18,032 shares of AbbVie worth $4.54M as of Q2 2026.
- Round Rock Advisors sold 48 AbbVie shares in Q2 2026, an estimated $10.3K.
- AbbVie made up 0.58% of Round Rock Advisors's portfolio in Q2 2026, its #22 holding.
- Round Rock Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
- 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Round Rock Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.